Business Context and Reporting Period
Chimera Investment Corporation filed a Form 8-K on April 15, 2009, reporting the entry into material definitive agreements regarding equity financing. The company is a Maryland corporation with principal executive offices in New York.
Key Financial Metrics and Transactions
- Public Offering: Agreement to sell 235,000,000 shares of Common Stock with an over-allotment option for an additional 35,250,000 shares.
- Private Placement: Agreement to sell 24,955,752 shares of Common Stock to Annaly Capital Management, Inc. at $3.00 per share.
- Estimated Net Proceeds (Public Offering): Approximately $674.8 million (excluding over-allotment).
- Estimated Net Proceeds (Private Placement): Approximately $74.9 million.
- Total Estimated Net Proceeds: Approximately $749.7 million (excluding over-allotment).
- Closing Date: Expected on April 21, 2009.
Material Changes
This filing represents a significant capital raise event. The company is executing a dual-track financing strategy involving a registered public offering and an unregistered private sale to a strategic investor (Annaly Capital Management). The private sale is contingent upon the closing of the public offering.
Guidance, Outlook, and Risks
The filing does not provide specific financial guidance, management commentary on future operations, or a discussion of risks beyond the standard contingencies of the transaction closing. The primary contingency noted is that the sale to Annaly Capital Management is dependent on the successful closing of the Public Offering.
Investor Verification Checklist
- Confirm the final closing date of the Public Offering and Private Placement (expected April 21, 2009).
- Verify the exercise of the 35,250,000 share over-allotment option and the resulting total proceeds.
- Review the final prospectus for the Public Offering to confirm the exact offering price per share.
- Assess the impact of the increased share count on earnings per share (EPS) and ownership dilution.